|

Neuroblastoma Biology Study

RECRUITINGSponsored by New Approaches to Neuroblastoma Therapy Consortium
Actively Recruiting
SponsorNew Approaches to Neuroblastoma Therapy Consortium
Started2011-07
Est. completion2099-12
Eligibility
Age31 Days – 99 Years
Healthy vol.Accepted
Locations16 sites
View on ClinicalTrials.gov →

NCT01587300

Summary

Medical scientists want to find better ways to treat neuroblastoma and to find ways to prevent the tumor from growing back. To do this, they need more information about the characteristics of neuroblastoma cells. Therefore, they want to study samples of neuroblastoma tissues and neuroblastoma and normal cells in the blood and bone marrow that may be related to the growth of neuroblastoma cells. Doctors and other medical scientists also want to find better ways to detect and measure neuroblastoma to improve the ability to follow the response of tumor cells to therapy.

Eligibility

Age: 31 Days – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients must be greater than or 31 days of age.
* Patients must have had a diagnosis of high risk neuroblastoma either by histological verification of neuroblastoma and/or demonstration of tumor cells in the bone marrow with increased urinary catecholamines.
* All patients with refractory or recurrent high risk neuroblastoma at NANT institutions are eligible regardless of disease status (including no measurable or evaluable tumor) as long as they undergo a disease evaluation and appropriate samples are submitted.
* Additionally, all patients with high risk neuroblastoma without relapse treated at a NANT institution are eligible if undergoing a disease evaluation, as long as Children's Oncology Group specimens are prioritized.

Exclusion Criteria:

* There are no exclusion criteria on this study.

Conditions2

CancerNeuroblastoma

Locations16 sites

Children's Hospital Los Angeles
Los Angeles, California, 90027-0700
Araz Marachelian, MD
Lucille Salter Packer Children's Hospital, Stanford University
Palo Alto, California, 94305
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94115
Kieuhoa Vo, MD
Children Hospital of Colorado
Aurora, Colorado, 80045
Margaret Macy, MD
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, 30322
Kelly Goldsmith, MD

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.